English
Application
QbD-Engineered Development and Validation of a RP-HPLC Method for Simultaneous Estimation of Rutin and Ciprofloxacin HCl in Bilosomal Nanoformulation.: This study leverages the Kromasil® C18 HPLC Column to develop a robust, quality-by-design (QbD) engineered method for simultaneous estimation of rutin and ciprofloxacin, enhancing analytical accuracy in pharmaceutical formulations (Shamim et al., 2023).
Green analytical chemistry and experimental design: a combined approach for the analysis of zonisamide.: Highlights the use of the Kromasil® C18 HPLC Column in implementing green analytical chemistry principles for the analysis of zonisamide, contributing to sustainable laboratory practices (Elsheikh et al., 2023).
Simple high-performance liquid chromatography-ultraviolet method for simultaneous separation and detection of 14 bisphenol pollutants in building materials.: Demonstrates the efficacy of the Kromasil® C18 HPLC Column in environmental analysis, particularly for the detection of bisphenol pollutants in construction materials, addressing significant environmental health concerns (Han et al., 2023).
Development and Validation for Quantification of 7-Nitroso Impurity in Sitagliptin by Ultraperformance Liquid Chromatography with Triple Quadrupole Mass Spectrometry.: This paper uses the Kromasil® C18 HPLC Column for the sensitive detection and quantification of impurities in pharmaceutical products, ensuring drug safety and compliance with regulatory standards (Chittireddy et al., 2022).
Simple and Sensitive RP-HPLC and UV Spectroscopic Methods for the Determination of Remogliflozin Etabonate in Pure and Pharmaceutical Formulations.: Utilizes the Kromasil®C18 HPLC Column to establish a simple and sensitive method for the analysis of Remogliflozin, aiding in the quality control and development of diabetes medication (Itigimatha et al., 2022).
Legal Information
Kromasil is a registered trademark of EKA Chemicals AB
